These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3376331)

  • 1. [Specific diagnosis of familial dysbetalipoproteinemia in Denmark. Report of a family study].
    Gerdes LU; Faergeman O
    Ugeskr Laeger; 1988 Jan; 150(4):230-2. PubMed ID: 3376331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperlipoproteinemia type III: genetic basis and environmental factors, diagnosis, and treatment].
    Pocoví M; Garcés C; Casao E; Cenarro A; Civeira F
    Rev Clin Esp; 1992 Nov; 191(8):444-50. PubMed ID: 1488520
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined familial hypercholesterolemia and type III hyperlipoproteinemia].
    Levy Y; Aviram M; Baruch Y; Brook JG
    Harefuah; 1984 Jun; 106(12):565-6. PubMed ID: 6479724
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia and accelerated atherosclerosis.
    Hazzard WR
    Hosp Pract (Off Ed); 1988 May; 23(5A):41-50. PubMed ID: 2967303
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH
    Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 10. [Familial hyperlipoproteinemia type III].
    Yamamura T
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1772-7. PubMed ID: 1479217
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
    Smelt AH; de Beer F
    Semin Vasc Med; 2004 Aug; 4(3):249-57. PubMed ID: 15630634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbetalipoproteinemia and clomipramine.
    Holmes DT; Long P; Frohlich J
    Am J Psychiatry; 2005 Jul; 162(7):1384-5. PubMed ID: 15994726
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.
    Havel RJ
    Med Clin North Am; 1982 Mar; 66(2):441-54. PubMed ID: 7040846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial apolipoprotein E deficiency.
    Schaefer EJ; Gregg RE; Ghiselli G; Forte TM; Ordovas JM; Zech LA; Brewer HB
    J Clin Invest; 1986 Nov; 78(5):1206-19. PubMed ID: 3771793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.
    Okubo M; Aoyama Y; Harada K; Fukawa M; Tsukada T; Mokuno H; Yamada N; Murase T
    Atherosclerosis; 1998 Sep; 140(1):187-90. PubMed ID: 9733231
    [No Abstract]   [Full Text] [Related]  

  • 18. Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
    Heidemann BE; Koopal C; Baass A; Defesche JC; Zuurbier L; Mulder MT; Roeters van Lennep JE; Riksen NP; Boot C; Marais AD; Visseren FLJ
    Clin Genet; 2022 Oct; 102(4):253-261. PubMed ID: 35781703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apolipoproteins and atherosclerosis--study of apolipoprotein E].
    Taniguchi T; Yamasaki S
    Rinsho Byori; 1984 Jul; 32(7):772-9. PubMed ID: 6389939
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial dysbetalipoproteinemia: a potentially fatal disorder.
    Bari AU; Hashim R; Rahman SB; Hussain M
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):506-8. PubMed ID: 18798589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.